Journal of Substance Abuse Treatment
Volume 37, Issue 3 , Pages 313-317 , October 2009

Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes

  • Jennifer G. Plebani, Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of Pennsylvania, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104, USA. Tel.: +1 215 222 3200x152; fax: +1 215 386 5106.
    • ,
  • Kyle M. Kampman, M.D.
    • ,
  • Kevin G. Lynch, Ph.D.

Received 2 April 2008 ,Revised 16 February 2009 ,Accepted 19 February 2009.

References 

  1. Alterman AI, Kampman K, Boardman CR, Cacciola JS, Rutherford MJ, McKay JR, et al. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence. 1997;46:79–85
  2. Alterman AI, McKay JR, Mulvaney FD, McLellan AT. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug and Alcohol Dependence. 1996;40:227–233
  3. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, et al. Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug and Alcohol Dependence. 2005;77:7–11
  4. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, et al. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence. 2006;81:267–274
  5. Doherty K, Kinnunen T, Militello FS, Garvey AJ. Urges to smoke during the first month of abstinence: Relationship to relapse and predictors. Psychopharmacology. 1995;119:171–178
  6. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine. 1989;12:159–182
  7. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. Predictors of smoking relapse among self-quitters: A report from the Normative Aging Study. Addictive Behaviors. 1992;17:367–377
  8. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. British Medical Journal. 1994;309:842–846
  9. Heil SH, Alessi SM, Lussier JP, Badger GJ, Higgins ST. An experimental test of the influence of prior cigarette smoking abstinence on future abstinence. Nicotine & Tobacco Research. 2004;6:471–479
  10. Higgins ST, Badger GJ, Budney AJ. Initial abstinence and success in achieving longer-term cocaine abstinence. Experimental and Clinical Psychopharmacology. 2000;8:377–386
  11. Higgins ST, Heil SH, Plebani Lussier J. Clinical implications of reinforcement as a determinant of substance use disorders. Annual Review of Psychology. 2004;55:431–461
  12. Kampman KM, Dackis C, Lynch KG, Pettinati HM, Tirado C, Gariti P, et al. A double-blind, placebo-controlled trial of amantadine and propranolol for the treatment of cocaine dependent patients with severe cocaine withdrawal symptoms. Drug and Alcohol Dependence. 2006;85:129–137
  13. Kampman KM, Volpicelli JR, Mulvaney F, Rukstalis M, Alterman AI, Pettinati H, et al. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors. 2002;27:251–260
  14. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: Who will quit with and without the nicotine patch. JAMA. 1994;271:589–593
  15. Levin FR, Bisaga A, Raby W, Aharonovich E, Rubin E, Mariani J, et al. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment. 2008;34:80–89
  16. Murphy SA. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine. 2005;24:1455–1481
  17. Pettinati HM, Kampman KM, Lynch KG, Xie H, Dackis C, Rabinowitz AR, et al. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addictive Behaviors. 2008;33:651–667
  18. Yudkin PL, Jones L, Lancaster T, Fowler GH. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. British Journal of General Practice. 1996;46:145–148

PII: S0740-5472(09)00027-0

doi: 10.1016/j.jsat.2009.02.001

Journal of Substance Abuse Treatment
Volume 37, Issue 3 , Pages 313-317 , October 2009

Article Tools